sayacare_log

Hey, User !

Select delivery location

Fill in New Patient Details

Welcome to SayaCare- India's only E-pharmacy that Tests every Batch👋FREE delivery on 1st order — Use coupon: TESTME101

sayacare_logosayacare_logo

Ambroxol 60 mg + Levocetirizine 5 mg

Testeddrug image
Testeddrug image
Testeddrug image
Testeddrug image
Testeddrug image

Ambroxol 60 mg + Levocetirizine 5 mg

Drug Code: 721

| tablettablet| Pack of 10 tablets
MRP ₹75.9

₹22

71% off

🔥141 People bought recently

Per unit price

₹ 2.2/tablets

Quality Lab Tested

This batch has been verified!

WHO- GMP

Sourced Medicines

Each Batch Tested

by SayaCare at Govt. Certified NABL

1,00,000+

Trusted customers

Batch Details

Composition

ambroxol (sr) 60 mg + levocetirizine 5 mg

Batch

69|PGT25-3452C

Expiry

November 2027

Brands with same SaltBut mostly higher prices

sinarest levo new tablet

₹ 132

fexil am tab

₹ 24

lidof a

₹ 35

atrite

₹ 35

lecee am

₹ 39

lecet am 5 mg 60 mg tablet

₹ 123

lecetzy am

₹ 39

levorax am tablet

₹ 75

zivocet al

₹ 30

hista am

₹ 78

Why Choose SayaCare ?

You pay for the medicine, not the brand name

Same active ingredients

Exact Same Dosage Type

Lab Tested Quality

Transparent Test Report

Batch Details

Composition

ambroxol (sr) 60 mg + levocetirizine 5 mg

Batch

69|PGT25-3452C

Expiry

November 2027

Medicine Highlights

Uses 1. To relieve throat irritation, sneezing, and runny nose caused by allergens like dust and pets’ hair. 
2. To treat wet cough. 
3. To improve mucus clearance. 
Common Side Effects  1. Sleepiness or feeling drowsy 
2. Tiredness or weakness 
3. Dry mouth 
4. Headache 
5. Feeling dizzy 
Additional Information It should not be given to children below 2 years 
Do not take more than the prescribed dose. 
Storage 1. The medicine should be stored at room temperature.
2. Keep away from sunlight and moisture.
3. Keep away from the reach of children
How to Take This MedicineTake this medicine orally with a sip of water. 

Ambroxol + Levocetirizine Uses

Ambroxol 60 mg + Levocetirizine 5 mg are a combination of mucolytics and antihisatimes and are used for treatment of 

  1. Throat irritation, sneezing, and runny nose caused by allergies triggered by dust or pet hairs and itchy or watery eyes (hay fever).  
  2. Wet cough 
  3. Mucus clearance. 

Ambroxol + Levocetirizine side effects

More Common  

  1. Sleepiness or feeling drowsy 
  2. Tiredness or weakness 
  3. Dry mouth 
  4. Headache 
  5. Feeling dizzy 

Less Common 

  1. Upset stomach or nausea 
  2. Sore throat 
  3. Nosebleed 
  4. Fast heartbeat 
  5. Trouble sleeping 
  6. Weight gain 
  7. Allergic reaction (swelling, rash, itching) 

How Ambroxol + Levocetirizine works

Ambroxol helps loosen and clear thick mucus from the lungs, making coughs less effective and breathing easier. Levocetirizine calms allergy reactions by blocking the body’s histamine response, reducing sneezing, itching, and stuffy nose.

Safety Measures and Warning

Allergy

Individuals with a known hypersensitivity or allergy to levocetirizine, cetirizine, or any ingredients in the formulation should avoid the drug because it may trigger severe allergic reactions

Kidney Disease

This medicine is removed through the kidneys, and weak kidneys can’t clear it properly, which can lead to side effects.

Infants and Young Children

Children under the age of 6 months should not use levocetirizine, and special caution is required for children up to 11 years old with pre-existing kidney issues due to increased risk of side effects.

Ambroxol + Levocetirizine Interaction with Food Product

Avoid consuming caffeinated foods, as they can cause side effects like allergies and skin rashes. Alcohol and smoking can increase the medicine’s side effects occurring and worsen the patient’s conditions.

Ambroxol + Levocetirizine Interaction with Other Medicines

Avoid taking levocetirizine with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal:

Ambroxol + Levocetirizine Chemical Structure

IUPAC (International Union of Pure and Applied Chemistry)/ Chemical name

Ambroxol- 4-[(2-amino-3,5-dibromophenyl) methylamino] cyclohexan-1-ol; hydrochloride

Levocetirizine- 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl] piperazin-1-yl]ethox acetic acid

Intake routine/cycle

Daily dose

Take Ambroxol + Levocetirizine exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.

Missed Dose

If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage.

Overdose

Do not take more than 100 mg of this medicine a day, as the dose increases the risk of serious overdosing effects such as drowsiness, confusion, agitation, and dizziness. If you know someone who takes this medicine and has these symptoms, then rush them to the hospital immediately.

Storage

  1. Store the medicine at room temperature. 
  2. Keep away from sunlight and moisture. 
  3. Keep out of reach of children. 

Directions for use

  1. Take Ambroxol + Levocetirizine exactly as prescribed by your doctor at the same time each day. 
  2. Do not stop taking Ambroxol + Levocetirizine without your doctor’s approval, even if you feel better. 
  3. If you forget to take Ambroxol + Levocetirizine, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose. 

Ambroxol + Levocetirizine Summary

Ambroxol 60 mg + levocetirizine 5 mg is a combination medicine where ambroxol (a mucolytic drug) thins and clears mucus from the lungs, and levocetirizine (an antihistamine) reduces allergy symptoms. It is commonly prescribed for coughing with mucus, allergic rhinitis, bronchitis, and breathing discomfort. Common side effects of this medicine include drowsiness, headaches, dry mouth, stomach upset, nausea, or diarrhea. Food does not interact with this medication, but taking it with alcohol can worsen drowsiness and stomach irritation. People with severe liver or kidney disease, stomach ulcers, or those who need to stay alert (like drivers) should avoid it. Taking more than 100 mg of this medicine can cause extreme sleepiness, confusion, stomach upset, or low blood pressure, and medical help is required immediately.

FAQ’s

What are the uses of ambroxol and levocetirizine combination medicine?

The combination of ambroxol and levocetirizine is mainly used to treat cough with mucus and allergy-related breathing problems. It helps clear mucus from the lungs while also reducing sneezing, itching, and nasal congestion caused by allergies.

What are the drug-drug interactions of ambroxol and levocetrizine tablets?

Ambroxol can interact with antibiotics by increasing their penetration into lung tissue, while levocetirizine may cause extra drowsiness if combined with sedatives, alcohol, or other antihistamines. Together, caution is needed with drugs affecting the liver or kidneys, as side effects like sleepiness, stomach upset, or reduced alertness may become stronger.

What are the side effects of ambroxol tablet?

Common side effects of ambroxol tablets include nausea, vomiting, stomach upset, diarrhea, and mild allergic reactions like rash or itching. Less common but possible effects are dry mouth, dizziness, or throat irritation, and people with stomach ulcers should use it cautiously.

How many doses of ambroxol + levocetirizine combinations can be used per day?

For adults, ambroxol + levocetirizine tablets are usually taken once or twice daily, depending on the doctor’s advice and the severity of symptoms. In some cases, dosing may start at one tablet three times daily for 2–3 days, then reduced to twice daily.

Reference

  1. Drugs.com. Ambroxol: Uses, Side Effects & Warnings [Internet]. Drugs.com; [cited 2026 Feb 26]. Available from. 
  2. DrugBank Online. Ambroxol: Uses, Interactions, Mechanism of Action. DrugBank ID: DB06742 [Internet]. DrugBank; [cited 2026 Feb 26]. Available from. 
  3. Kantar A, Klimek L, Cazan D, Sperl A, Sent U, Mesquita M. An overview of efficacy and safety of ambroxol for the treatment of acute and chronic respiratory diseases with a special regard to children. Multidiscip Respir Med.Available from. 
  4. PubChem [Internet]. Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information; 2004-. PubChem Compound Summary for CID 108013.Available from. 
  5. Drugs.com. Levocetirizine: Uses, Dosage, Side Effects & Warnings [Internet]. Drugs.com; [cited 2026 Feb 26]. Available from. 
  6. Mayo Clinic. Levocetirizine (oral route): Side effects & dosage [Internet]. Rochester (MN): Mayo Foundation for Medical Education and Research; c2026 [cited 2026 Feb 26]. Available from. 

Siva Krishna Adithya Bhumireddy avatar

Written By-

Siva Krishna Adithya Bhumireddy

Medical content writer

Bachelors in Pharmacy | 1+ Year experience

Mahak Phartyal avatar

Reviewed By-

Mahak Phartyal

Medical Content writer and reviewer

Bachelors in Pharmacy | 3+ Year experience

Last Updated: 31 Mar 2026

Similar Items

India's OnlyE- Pharmacy
That Tests Every Medicine Batch.

Tested hai, Toh bharosa hai!

Safe medicines

-Rigorously Tested-

Quality Reports

-Full Transparency-

Low Prices

-Save up to 80%-

Home Delivery

-Fast & Reliable-

Disclaimer

All brand names, trademarks, trade dress, logos, and product names of third parties appearing on SayaCare are the property of their respective owners and are protected under applicable intellectual property laws, including the Trade Marks Act, 1999. SayaCare claims no ownership over, or association with, any such third-party intellectual property.

Third-party brand names and trademarks are referenced on this platform for the purposes of product identification and to assist users in locating generic or equivalent alternatives, in accordance with honest commercial practices under the Trade Marks Act, 1999. Such references do not form part of SayaCare's own branding or promotional identity.

SayaCare is an independent platform and is not affiliated with, endorsed by, sponsored by, or acting as an authorised agent or distributor of any brand referenced herein, and makes no such representation to consumers. The appearance of any brand name on this platform does not imply any formal partnership, endorsement, or direct commercial relationship with the respective brand owner.

Where SayaCare provides information on the generic equivalence of any product to a branded medicine, such information is based on publicly available regulatory data, including schedules under the Drugs and Cosmetics Act, 1940, and information published by the CDSCO. Any editorial content, ratings, or commentary represents the independent views of the platform and should not be attributed to any third-party brand. Neither should be construed as a statement regarding a brand's overall performance or reputation.

All information on this platform is for general awareness only and does not constitute medical advice. Users are strongly advised to consult a registered medical practitioner or licensed pharmacist before substituting any branded medicine with a generic alternative or acting on any information available here. SayaCare is not responsible for brand references or opinions expressed by users in reviews or uploaded content, which represent the views of individual users alone. Users are prohibited from uploading content that infringes the intellectual property rights of any third party.

SayaCare respects the intellectual property rights of all brand owners and does not intend to infringe upon any trademark, trade dress, or related right. If you believe any content on this platform infringes your rights, please contact our IP Grievance Officer at [email protected] . All bona fide complaints will be reviewed within 7 business days and appropriate remedial action taken where infringement is established. This mechanism is maintained in accordance with the Information Technology (Intermediary Guidelines and Digital Media Ethics Code) Rules, 2021.